Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Symptoms

The Effects of Cancer on Family Life

Insight into Cancer Vaccines

Insights into Oncofertility

CDK9 and Cancer

Effects of Social and Economic Deprivation on Cancer Mortality

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Secondary Lung Cancer

Hypoxia Markers and Their Importance

See more featured articles »

Cancer Management

Using Biomarkers to Detect Cancer

Cancer Pain Management

Cancer History

Caring for a Loved One with Cancer

Assay for Monitoring and Treating Malignant Brain Tumors

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Investigating the Molecular Mechanisms of Cancer

Cancer Prevention: Lowering your Risk

The Cancer Cell Surface Proteome as a Therapeutic Target

Pediatric Cancer

Cutaneous Manifestations of Internal Malignancy

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

British Pioneers in Cancer Biology

Cancer Pathophysiology

Transforming Cancer Care through Genomic Testing

What is Merkel Cell Carcinoma?

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Research

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Pain

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cancer Prognosis

Targeted Cancer Therapies

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Glossary

The Biochemistry of Breast Cancer Screening

Why are Cancer Cell Lines Useful?

What is Cancer?

Secondary Brain Cancer

What is Cancer of Unknown Primary?

Is Cancer a Metabolic Disorder?

Hot vs Cold: the differences between tumor types

What is the Tumor Microenvironment?

Cancer Epidemiology

Cancer Screening Considerations: Balancing the Benefits and Risks

Myc Mutations and Cancer

What is Immunochemotherapy?

What Role do Biobanks Play in Cancer Research?

Acidosis and Tumor Progression

Microfluidic cancer treatment screen combined with flow cytometry

What Causes Cancer?

Cancer Diagnosis

Cancer Classification

Exploiting Enzymes in Cancer Diagnosis and Therapy

Living with Cancer Pain

What is Tumorigenesis?

Overview of Cell Viability and Cytotoxicity

Latest Cancer News and Research

New report urges unified lifecycle approach to women's heart health

A new approach to women's heart health may offer them a lifetime of opportunities. A trio of scientific papers, published today in the journal Circulation, spells out how fluctuating hormones, mental health and well-being, the heart and the brain are linked and how those connections need to be a routine part of care from a young age.

26 Oct 2026

Black patients and people with learning disability face longer breast cancer care delays

Black patients and people with a learning disability face longer waiting times at key stages of breast cancer care, according to a nationwide study led by the University of Surrey.

26 Oct 2026

Study reveals a broad shift away from overtreatment of low-risk prostate cancer

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer.

26 Oct 2026

Clues to prostate cancer risk in blood samples taken 15 years earlier

Recent study links blood proteins to aggressive prostate cancer, identifying potential biomarkers for early risk prediction and insights into immune activity.

26 Oct 2026

New archiving technique reveals past gene activity in cells

Information on what a cell did a few hours or days ago is generally unavailable to researchers, who can only measure the cell's current status.

26 Oct 2026

Taking a GLP-1 drug? Here's what the safety evidence really shows

A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.

26 Oct 2026

Next generation KRAS inhibitor divarasib significantly extends lung cancer survival

Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS targeted therapy divarasib, according to researchers from The University of Texas MD Anderson Cancer Center.

26 Oct 2026

Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPA

Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026.

26 Oct 2026

Beer, wine or spirits: A large study finds different mortality patterns for each

Researchers analyzed data from 340,924 UK Biobank participants and found that high total alcohol consumption was associated with greater all-cause, cardiovascular, and cancer mortality, while moderate consumption was linked to increased cancer mortality. Beer/cider and spirits showed associations with higher mortality across several outcomes, whereas low-to-moderate wine consumption was linked to lower mortality for certain outcomes, though the observational study cannot establish causation.

25 Oct 2026

Personalized mRNA cancer vaccine cuts melanoma recurrence risk when added to immunotherapy

Adding a personalized mRNA-based cancer vaccine to immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, according to results from the phase 3 INTerpath-001 trial presented at the ESMO Congress 2026.

24 Oct 2026

Abiraterone triplet therapy improves long-term survival in metastatic prostate cancer

Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread at diagnosis, reinforcing the value of early treatment intensification.

24 Oct 2026

Drug combination delivers promising survival gains in advanced endometrial cancer

An immunotherapy-based regimen combining durvalumab and the PARP inhibitor, olaparib, demonstrated encouraging long-term survival outcomes for patients with advanced or recurrent endometrial cancer, according to new trial results presented by researchers from The University of Texas MD Anderson Cancer Center.

24 Oct 2026

PFAS levels in United States drinking water may be underestimated

Common ways of reporting perfluoroalkyl and polyfluoroalkyl substances (PFAS)-the man-made, so-called forever chemicals that pose environmental and health threats-could underestimate the concentration of PFAS in United States drinking water by as much as half, finds a study publishing October 23 in the Cell Press journal Cell Reports Sustainability.

24 Oct 2026

Doctors explain why breast cancer screening should start at age 40

Advances in breast cancer screening and treatment are helping doctors detect the disease earlier, tailor therapies to individual patients and, in some cases, spare women from unnecessary chemotherapy, radiation and surgery.

24 Oct 2026

Nearly one third of patients with advanced melanoma saw tumors disappear completely after receiving TIL therapy plus pembrolizumab immunotherapy

Results from a clinical trial have revealed nearly one third (29.2 percent) of patients with advanced melanoma saw their tumors disappear completely on scans after receiving lifileucel TIL therapy alongside an immune checkpoint inhibitor, pembrolizumab, as a first-line treatment.

24 Oct 2026

Six-gene score could improve survival predictions for acute myeloid leukemia

The activity of six different genes can help determine patient survival of acute myeloid leukemia (AML), according to a study published today in Science Advances.

23 Oct 2026

Study reveals how cancer cells survive chemotherapy in a zombie-like state

Scientists at Trinity College Dublin have made an important breakthrough in understanding how cancer cells can evade the cell-killing effects of chemotherapy and enter a "zombie-like state", called premature senescence, that can attract the wound healing properties of the immune system.

23 Oct 2026